NeuroSense Therapeutics Ltd. (NRSN)

NASDAQ: NRSN · IEX Real-Time Price · USD

0.732

-0.029 (-3.76%)

At close: Jul 19, 2024, 4:00 PM

0.760

+0.028 (3.88%)

Pre-market: Jul 22, 2024, 6:54 AM EDT

NeuroSense Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	13	10	14	26
Market Cap Growth	-29.61%	-29.61%	-47.52%	-
Enterprise Value	11	7	7	15
PE Ratio	-	-0.97	-1.32	-8.23
PB Ratio	-5.56	-5.56	2.38	2.94
P/FCF Ratio	-1.17	-1.17	-1.81	-17.02
P/OCF Ratio	-1.17	-1.17	-1.83	-17.21
EV/EBITDA Ratio	-0.72	-0.72	-0.66	-4.80
EV/EBIT Ratio	-0.71	-0.71	-0.66	-4.79
EV/FCF Ratio	-0.86	-0.86	-0.91	-9.91
Debt / Equity Ratio	-0.04	-0.04	0.03	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-
Debt / FCF Ratio	-0.01	-0.01	-0.02	-
Quick Ratio	0.83	0.83	4.26	19.05
Current Ratio	0.84	0.84	4.28	19.12
Return on Equity (ROE)	6616.70%	6616.70%	-117.80%	-66.60%
Return on Assets (ROA)	-185.70%	-185.70%	-98.20%	-52.70%
Return on Capital (ROIC)	714.65%	714.65%	-176.16%	-33.14%
Earnings Yield	-76.59%	-103.30%	-75.48%	-12.16%
FCF Yield	-63.53%	-85.68%	-55.29%	-5.87%
Buyback Yield / Dilution	-18.56%	-18.56%	-84.27%	-13.12%
Total Shareholder Return	-18.56%	-18.56%	-84.27%	-13.12%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).